BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22244910)

  • 21. Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study.
    Erkens JA; Panneman MM; Klungel OH; van den Boom G; Prescott MF; Herings RM
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):795-803. PubMed ID: 16178043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.
    Feringa HH; Bax JJ; Karagiannis SE; Noordzij P; van Domburg R; Klein J; Poldermans D
    Arch Gerontol Geriatr; 2009; 48(1):116-20. PubMed ID: 18177954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive persistence and drug class.
    Marentette MA; Gerth WC; Billings DK; Zarnke KB
    Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventing recurrent events long term after coronary artery bypass graft: suboptimal use of medications in a population study.
    Bradshaw PJ; Jamrozik K; Gilfillan I; Thompson PL
    Am Heart J; 2004 Jun; 147(6):1047-53. PubMed ID: 15199354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age, sex, and secondary prevention of ischaemic heart disease in everyday practice.
    Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Surowiec S; Loster M; Bogacki P; Bryniarska-Mirek E; Grodecki J; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
    Kardiol Pol; 2013; 71(12):1251-9. PubMed ID: 23799620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organising a nurse-driven PAD rehabilitation clinic within the vascular surgical department: what is required and are treatment goals reached--a prospective study?
    Sillesen H; Madelung S; Eldrup N; Roed M
    Eur J Vasc Endovasc Surg; 2007 Jan; 33(1):26-32. PubMed ID: 17070079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive drug treatment in a Swedish community: Skaraborg Hypertension and Diabetes Project.
    Bøg-Hansen E; Lindblad U; Ranstam J; Melander A; Råstam L
    Pharmacoepidemiol Drug Saf; 2002; 11(1):45-54. PubMed ID: 11998551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical risk factor treatment in peripheral arterial disease. Need for further improvement.
    Alhadad A; Wictorsson C; Alhadad H; Lindblad B; Gottsäter A
    Int Angiol; 2013 Jun; 32(3):332-8. PubMed ID: 23711686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM
    Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive drug-associated sexual dysfunction: a prescription analysis-based study.
    al Khaja KA; Sequeira RP; al Damanhori AH; Mathur VS
    Pharmacoepidemiol Drug Saf; 2003; 12(3):203-12. PubMed ID: 12733473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry.
    Eisenberg MJ; Okrainec K; Lefkovits J; Goudreau E; Deligonul U; Mak KH; Duerr R; Tsang J; Huynh T; Sedlis S; Brown DL; Brieger D; Pilote L;
    Can J Cardiol; 2003 Aug; 19(9):1009-15. PubMed ID: 12915928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal trends in the incidence and recurrence of hospitalised atherothrombotic disease in an Australian population, 2000-07: data linkage study.
    Nedkoff L; Briffa TG; Knuiman M; Hung J; Norman PE; Hankey GJ; Thompson PL; Geelhoed E; Sanfilippo FM; Hickling S; Bremner A; Hobbs M
    Heart; 2012 Oct; 98(19):1449-56. PubMed ID: 22821274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication underuse during long-term follow-up in patients with peripheral arterial disease.
    Hoeks SE; Scholte op Reimer WJ; van Gestel YR; Schouten O; Lenzen MJ; Flu WJ; van Kuijk JP; Latour C; Bax JJ; van Urk H; Poldermans D
    Circ Cardiovasc Qual Outcomes; 2009 Jul; 2(4):338-43. PubMed ID: 20031859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical prophylaxis following hospitalization for ischemic stroke: age- and sex-related differences and relation to mortality.
    Palnum KH; Mehnert F; Andersen G; Ingeman A; Krog BR; Bartels PD; Johnsen SP
    Cerebrovasc Dis; 2010; 30(6):556-66. PubMed ID: 20948199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease.
    Sigvant B; Wiberg-Hedman K; Bergqvist D; Rolandsson O; Wahlberg E
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):39-46. PubMed ID: 19237996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.